![Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/8/6/e1096/F4.large.jpg)
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
![Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis](https://www.mdpi.com/cells/cells-08-00927/article_deploy/html/images/cells-08-00927-g001.png)
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
![CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1) CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1)](https://www.thermofisher.com/antibody/images/650/959-MSM1-P1-CD154-CD40-Ligand-ICC-IF-1-20210513143032.jpg?time=20220826)
CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1)
![CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1) CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1)](https://www.thermofisher.com/antibody/images/650/959-MSM3-P1-CD154-CD40-Ligand-ICC-IF-1-20210513143032.jpg?time=20220826)
CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1)
![Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade | Molecular Cancer | Full Text Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-021-01366-y/MediaObjects/12943_2021_1366_Figa_HTML.png)
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade | Molecular Cancer | Full Text
![Surface marker expression of CD66b, HLA-DR, CD11c, CD40, CD86, and CD86... | Download Scientific Diagram Surface marker expression of CD66b, HLA-DR, CD11c, CD40, CD86, and CD86... | Download Scientific Diagram](https://www.researchgate.net/profile/Xiaohuan-Chen/publication/333634249/figure/fig1/AS:766505532809223@1559760568832/Surface-marker-expression-of-CD66b-HLA-DR-CD11c-CD40-CD86-and-CD86-in-synovial-fluid_Q320.jpg)
Surface marker expression of CD66b, HLA-DR, CD11c, CD40, CD86, and CD86... | Download Scientific Diagram
![JCI Insight - Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients JCI Insight - Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients](https://df6sxcketz7bb.cloudfront.net/manuscripts/145000/145389/medium/jci.insight.145389.f5.jpg)